Organon & Co | OGN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Bristol-Myers Squibb 16.14 7.06 2026-06
Celltrion 58.97 8.86 2026-03
Cspc Pharmaceutical 23.62 0.78 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 58.35 1.4 2026-06
Gilead Sciences 13.51 4.2 2026-06
Glaxosmithkline 15.09 3.43 2026-03
Kangmei Pharma 1.11K 2.04K 2026-03
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Merck 32.26 15.74 2026-06
Neuren Pharmaceuticals 72.14 59.86 2025-12
Novartis 21.36 3.57 2026-03
Organigram Holdings 12.01 222.99 2026-03
Organon & Co 14.56 6.24 2026-06
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 16.35 2.78 2026-06
Qiagen NV 16.72 2.76 2026-06
Sartorius 52.99 9.56 2026-06
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
Zealand Pharma A/S 3.27 1.86 2026-03